|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 15-08-04 | Hospira : Pfizer wins EU approval for $15 billion Hospira buy | RE |
| 15-07-27 | Allergan : Mylan independence from Teva's embrace comes with a price | RE |
Company details: Hospira, Inc.
Group companies: Hospira, Inc.
| Name | Category and Sector |
|---|---|
Hospira UK Ltd.
 Hospira UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products |
Pharmaceuticals: Major
|
Generic Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.42% | -2.78% | +17.99% | +65.19% | 47.73B | |
| -0.93% | -3.94% | +37.57% | +118.92% | 40.21B | |
| -0.47% | -1.27% | +10.03% | +81.29% | 12.05B | |
| -0.59% | -2.75% | -11.45% | +10.15% | 11.79B | |
| -0.76% | -1.70% | +20.93% | +136.36% | 9.16B | |
| -1.02% | -4.04% | +21.19% | +33.90% | 7.34B | |
| -2.21% | -3.93% | +35.99% | -16.77% | 7.39B | |
| -1.59% | -1.08% | +14.98% | +200.07% | 7.37B | |
| -0.77% | -2.48% | -46.84% | +21.17% | 5.13B | |
| Average | -0.97% | -2.15% | +11.16% | +72.25% | 16.46B | |
| Weighted average by Cap. | -0.75% | -2.75% | +19.15% | +80.64% |
- Stock Market
- Stocks
- Stock
- Company Hospira, Inc.
Select your edition
All financial news and data tailored to specific country editions
